Chinese Journal of Antituberculosis ›› 2020, Vol. 42 ›› Issue (8): 869-873.doi: 10.3969/j.issn.1000-6621.2020.08.017
• Review Articles • Previous Articles Next Articles
CHEN Ning, SUN Lin, SHEN A-dong, HE Qiu-shui*()
Received:
2020-06-07
Online:
2020-08-10
Published:
2020-08-10
Contact:
HE Qiu-shui
E-mail:qiuhe@utu.fi
CHEN Ning, SUN Lin, SHEN A-dong, HE Qiu-shui. Possible causes of infection after BCG vaccination[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 869-873. doi: 10.3969/j.issn.1000-6621.2020.08.017
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2020.08.017
第一作者 | 发表 | 人群 | 卡介苗 | MSMD | 卡介苗感染 | 是否有患者 | 基因缺陷 |
---|---|---|---|---|---|---|---|
参考文献 | 年份 | 接种例数 | 患者例数 | 患者例数 | 来自同一家族 | ||
Sasaki[ | 2002 | 日本 | 6 | 6 | 6 | 否 | IFN-γR1 |
Picard[ | 2002 | 巴基斯坦、印度、沙特阿拉伯 | 11 | 13 | 11 | 是 | IL-12B |
Fieschi[ | 2003 | 全球17个国家 | 27 | 41 | 18 | 是 | IL-12Rβ1 |
Lichtenauer-Kaligis[ | 2003 | 土耳其 | 11 | 11 | 11 | 是 | IL-12Rβ1 |
Newport[ | 2004 | 美国、英国、土耳其、突尼斯等 | 24 | 60 | 20 | 是 | IFN-γR1 |
Chapgier[ | 2006 | 德国 | 3 | 3 | 2 | 否 | STAT1 |
Filipe-Santos[ | 2006 | 法国、德国 | 1 | 3 | 0 | 否 | NEMO |
de Beaucoudrey[ | 2010 | 全球30个国家 | 114 | 141 | 65 | 是 | IL-12Rβ1 |
Sologuren[ | 2011 | 葡萄牙、波兰、智利、西班牙 | 7 | 14 | 6 | 是 | IFN-γR1 |
Bustamante[ | 2011 | 法国 | 6 | 7 | 6 | 是 | CYBB |
Hambleton[ | 2011 | 爱尔兰、意大利 | 3 | 3 | 3 | 否 | IRF8 |
Bogunovic[ | 2012 | 土耳其、伊朗 | - | 3 | - | 是 | ISG15 |
Prando[ | 2013 | 印度、伊朗、巴基斯坦、沙特阿拉伯、突尼斯 | 41 | 49 | 40 | 是 | IL-12B |
Kong[ | 2013 | 波兰、法国 | 3 | 4 | 3 | 是 | IFN-γR2 |
Kreins[ | 2015 | 日本、土耳其、摩洛哥、伊朗、阿根廷 | 8 | 2 | 4 | 是 | TYK2 |
Okada[ | 2015 | 巴勒斯坦、智利、沙特阿拉伯 | 4 | 7 | 4 | 是 | RORC |
Eletto[ | 2016 | 巴基斯坦 | 1 | 1 | 0 | 否 | JAK1 |
Oleaga-Quintas[ | 2018 | 土耳其、印度 | 3 | 3 | 3 | 是 | IFN-γR2 |
Alodayani[ | 2018 | 沙特阿拉伯 | 3 | 3 | 3 | 是 | IL-12B |
Kong[ | 2018 | 摩洛哥、土耳其 | 3 | 3 | 3 | 是 | SPPL2A |
Martínez-Barricarte[ | 2018 | 土耳其、伊朗 | - | 3 | - | 是 | IL-12Rβ1、IL-23R |
[1] |
Peck M, Gacic-Dobo M, Diallo MS, et al. Global Routine Vaccination Coverage, 2018. MMWR Morb Mortal Wkly Rep, 2019,68(42):937-942. doi: 10.15585/mmwr.mm6842a1.
doi: 10.15585/mmwr.mm6842a1 URL pmid: 31647786 |
[2] |
World Health Organization. BCG Vaccine: WHO Position Paper, February 2018-Recommendations. Vaccine, 2018,36(24):3408-3410. doi: 10.1016/j.vaccine.2018.03.009.
doi: 10.1016/j.vaccine.2018.03.009 URL pmid: 29609965 |
[3] |
Düppre NC, Camacho LA, da Cunha SS, et al. Effectiveness of BCG vaccination among leprosy contacts: a cohort study. Trans R Soc Trop Med Hyg, 2008,102(7):631-638. doi: 10.1016/j.trstmh.2008.04.015.
doi: 10.1016/j.trstmh.2008.04.015 URL pmid: 18514242 |
[4] |
Portaels F, Aguiar J, Debacker M, et al. Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease. Infect Immun, 2004,72(1):62-65. doi: 10.1128/iai.72.1.62-65.2004.
doi: 10.1128/iai.72.1.62-65.2004 URL pmid: 14688081 |
[5] |
Curtis N, Sparrow A, Ghebreyesus TA, et al. Considering BCG vaccination to reduce the impact of COVID-19. Lancet, 2020,395(10236):1545-1546. doi: 10.1016/S0140-6736(20)31025-4.
doi: 10.1016/S0140-6736(20)31025-4 URL pmid: 32359402 |
[6] | Barkai G, Somech R, Stauber T, et al. Bacille Calmette-Guerin (BCG) complications in children with severe combined immunodeficiency (SCID). Infect Dis (Lond), 2019,51(8):585-592. doi: 10.1080/23744235.2019.1628354. |
[7] |
Fekrvand S, Yazdani R, Olbrich P, et al. Primary Immunodeficiency Diseases and Bacillus Calmette-Guérin (BCG)-Vaccine-Derived Complications: A Systematic Review. J Allergy Clin Immunol Pract, 2020,8(4):1371-1386. doi: 10.1016/j.jaip.2020.01.038.
doi: 10.1016/j.jaip.2020.01.038 URL pmid: 32006723 |
[8] |
Hassanzad M, Valinejadi A, Darougar S, et al. Disseminated Bacille Calmette-Guérin infection at a glance: a mini review of the literature. Adv Respir Med, 2019,87(4):239-242. doi: 10.5603/ARM.2019.0040.
doi: 10.5603/ARM.2019.0040 URL pmid: 31476012 |
[9] |
Li T, Zhou X, Ling Y, et al. Genetic and Clinical Profiles of Disseminated Bacillus Calmette-Guérin Disease and Chronic Granulomatous Disease in China. Front Immunol, 2019,10:73. doi: 10.3389/fimmu.2019.00073.
doi: 10.3389/fimmu.2019.00073 URL pmid: 30761141 |
[10] |
Wu W, Liu D, Nuorti JP, et al. Deaths reported to national surveillance for adverse events following immunization in China, 2010—2015. Vaccine, 2019,37(9):1182-1187. doi: 10.1016/j.vaccine.2019.01.009.
doi: 10.1016/j.vaccine.2019.01.009 URL pmid: 30709723 |
[11] |
Pöyhönen L, Bustamante J, Casanova JL, et al. Life-Threa-tening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity. J Clin Immunol, 2019,39(4):376-390. doi: 10.1007/s10875-019-00642-3.
doi: 10.1007/s10875-019-00642-3 URL pmid: 31123910 |
[12] |
Casanova JL, Jouanguy E, Lamhamedi S, et al. Immunological conditions of children with BCG disseminated infection. Lancet, 1995,346(8974):581. doi: 10.1016/s0140-6736(95)91421-8.
doi: 10.1016/s0140-6736(95)91421-8 URL pmid: 7658805 |
[13] |
Marciano BE, Huang CY, Joshi G, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol, 2014,133(4):1134-1141. doi: 10.1016/j.jaci.2014.02.028.
doi: 10.1016/j.jaci.2014.02.028 URL pmid: 24679470 |
[14] |
Roos D. Chronic granulomatous disease. Br Med Bull, 2016,118(1):50-63. doi: 10.1093/bmb/ldw009.
doi: 10.1093/bmb/ldw009 URL pmid: 26983962 |
[15] |
Ying W, Sun J, Liu D, et al. Clinical characteristics and immunogenetics of BCGosis/BCGitis in Chinese children: a 6 year follow-up study. PLoS One, 2014,9(4):e94485. doi: 10.1371/journal.pone.0094485.
doi: 10.1371/journal.pone.0094485 URL pmid: 24722620 |
[16] |
Zhou Q, Hui X, Ying W, et al. A Cohort of 169 Chronic Granulomatous Disease Patients Exposed to BCG Vaccination: a Retrospective Study from a Single Center in Shanghai, China (2004—2017). J Clin Immunol, 2018,38(3):260-272. doi: 10.1007/s10875-018-0486-y.
doi: 10.1007/s10875-018-0486-y URL pmid: 29560547 |
[17] |
Conti F, Lugo-Reyes SO, Blancas Galicia L, et al. Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases. J Allergy Clin Immunol, 2016,138(1):241-248. doi: 10.1016/j.jaci.2015.11.041.
doi: 10.1016/j.jaci.2015.11.041 URL pmid: 26936803 |
[18] |
Baba LA, Ailal F, El Hafidi N, et al. Chronic granulomatous disease in Morocco: genetic, immunological, and clinical features of 12 patients from 10 kindreds. J Clin Immunol, 2014,34(4):452-458. doi: 10.1007/s10875-014-9997-3.
doi: 10.1007/s10875-014-9997-3 URL |
[19] | Movahedi Z, Norouzi S, Mamishi S, et al. BCGiosis as a pre-senting feature of a child with chronic granulomatous disease. Braz J Infect Dis, 2011,15(1):83-86. doi: 10.1016/s1413-8670(11)70146-5. |
[20] |
Kawashima H, Hasegawa D, Nakamura M, et al. Hazards of early BCG vaccination: BCGitis in a patient with chronic granulo-matous disease. Pediatr Int, 2007,49(3):418-419. doi: 10.1111/j.1442-200X.2007.02383.x.
doi: 10.1111/j.1442-200X.2007.02383.x URL pmid: 17532851 |
[21] |
Al-Hammadi S, Alsuwaidi AR, Alshamsi ET, et al. Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency. BMC Res Notes, 2017,10(1):177. doi: 10.1186/s13104-017-2499-7.
doi: 10.1186/s13104-017-2499-7 URL pmid: 28476145 |
[22] |
Picard C, Bobby Gaspar H, Al-Herz W, et al. International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity. J Clin Immunol, 2018,38(1):96-128. doi: 10.1007/s10875-017-0464-9.
doi: 10.1007/s10875-017-0464-9 URL pmid: 29226302 |
[23] |
Pasic S, Lilic D, Pejnovic N, et al. Disseminated Bacillus Calmette-Guérin infection in a girl with hyperimmunoglobulin E syndrome. Acta Paediatr, 1998,87(6):702-704. doi: 10.1080/080352598750014166.
doi: 10.1080/080352598750014166 URL pmid: 9686668 |
[24] |
Bustamante J. Mendelian susceptibility to mycobacterial di-sease: recent discoveries. Hum Genet, 2020,139(6/7):993-1000. doi: 10.1007/s00439-020-02120-y.
doi: 10.1007/s00439-020-02120-y URL |
[25] |
Rosain J, Kong XF, Martinez-Barricarte R, et al. Mendelian susceptibility to mycobacterial disease: 2014—2018 update. Immunol Cell Biol, 2019,97(4):360-367. doi: 10.1111/imcb.12210.
doi: 10.1111/imcb.12210 URL pmid: 30264912 |
[26] |
Picard C, Fieschi C, Altare F, et al. Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet, 2002,70(2):336-348. doi: 10.1086/338625.
doi: 10.1086/338625 URL pmid: 11753820 |
[27] |
Alodayani AN, Al-Otaibi AM, Deswarte C, et al. Mendelian Susceptibility to Mycobacterial Disease Caused by a Novel Founder IL12B Mutation in Saudi Arabia. J Clin Immunol, 2018,38(3):278-282. doi: 10.1007/s10875-018-0490-2.
doi: 10.1007/s10875-018-0490-2 URL pmid: 29589181 |
[28] |
Kong XF, Martinez-Barricarte R, Kennedy J, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol, 2018,19(9):973-985. doi: 10.1038/s41590-018-0178-z.
doi: 10.1038/s41590-018-0178-z URL pmid: 30127434 |
[29] |
Martínez-Barricarte R, Markle JG, Ma CS, et al. Human IFN-γ immunity to mycobacteria is governed by both IL-12 and IL-23. Sci Immunol, 2018,3(30):eaau6759. doi: 10.1126/sciimmunol.aau6759.
doi: 10.1126/sciimmunol.aau6759 URL pmid: 30578351 |
[30] |
Sasaki Y, Nomura A, Kusuhara K, et al. Genetic basis of patients with bacille Calmette-Guérin osteomyelitis in Japan: identification of dominant partial interferon-gamma receptor 1 deficiency as a predominant type. J Infect Dis, 2002,185(5):706-709. doi: 10.1086/339011.
doi: 10.1086/339011 URL pmid: 11865431 |
[31] |
Fieschi C, Dupuis S, Catherinot E, et al. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med, 2003,197(4):527-535. doi: 10.1084/jem.20021769.
doi: 10.1084/jem.20021769 URL pmid: 12591909 |
[32] |
Lichtenauer-Kaligis EG, de Boer T, Verreck FA, et al. Severe Mycobacterium bovis BCG infections in a large series of novel IL-12 receptor beta1 deficient patients and evidence for the existence of partial IL-12 receptor beta1 deficiency. Eur J Immunol, 2003,33(1):59-69. doi: 10.1002/immu.200390008.
doi: 10.1002/immu.200390008 URL pmid: 12594833 |
[33] |
Newport M, Levin M, Roesler J, et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet, 2004,364(9451):2113-2121. doi: 10.1016/S0140-6736(04)17552-1.
doi: 10.1016/S0140-6736(04)17552-1 URL pmid: 15589309 |
[34] |
Chapgier A, Boisson-Dupuis S, Jouanguy E, et al. Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLoS Genet, 2006,2(8):e131. doi: 10.1371/journal.pgen.0020131.
doi: 10.1371/journal.pgen.0020131 URL pmid: 16934001 |
[35] |
Filipe-Santos O, Bustamante J, Haverkamp MH, et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med, 2006,203(7):1745-1759. doi: 10.1084/jem.20060085.
doi: 10.1084/jem.20060085 URL pmid: 16818673 |
[36] |
de Beaucoudrey L, Samarina A, Bustamante J, et al. Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore), 2010,89(6):381-402. doi: 10.1097/MD.0b013e3181fdd832.
doi: 10.1097/MD.0b013e3181fdd832 URL |
[37] |
Sologuren I, Boisson-Dupuis S, Pestano J, et al. Partial recessive IFN-γR1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindreds. Hum Mol Genet, 2011,20(8):1509-1523. doi: 10.1093/hmg/ddr029.
doi: 10.1093/hmg/ddr029 URL pmid: 21266457 |
[38] |
Bustamante J, Arias AA, Vogt G, et al. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol, 2011,12(3):213-221. doi: 10.1038/ni.1992.
doi: 10.1038/ni.1992 URL pmid: 21278736 |
[39] |
Hambleton S, Salem S, Bustamante J, et al. IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med, 2011,365(2):127-138. doi: 10.1056/NEJMoa1100066.
doi: 10.1056/NEJMoa1100066 URL pmid: 21524210 |
[40] |
Bogunovic D, Byun M, Durfee LA, et al. Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency. Science, 2012,337(6102):1684-1688. doi: 10.1126/science.1224026.
doi: 10.1126/science.1224026 URL pmid: 22859821 |
[41] |
Prando C, Samarina A, Bustamante J, et al. Inherited IL-12p40 deficiency: genetic, immunologic, and clinical features of 49 patients from 30 kindreds. Medicine (Baltimore), 2013,92(2):109-122. doi: 10.1097/MD.0b013e31828a01f9.
doi: 10.1097/MD.0b013e31828a01f9 URL |
[42] |
Kong XF, Vogt G, Itan Y, et al. Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease. Hum Mol Genet, 2013,22(4):769-781. doi: 10.1093/hmg/dds484.
doi: 10.1093/hmg/dds484 URL pmid: 23161749 |
[43] |
Kreins AY, Ciancanelli MJ, Okada S, et al. Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome. J Exp Med, 2015,212(10):1641-1662. doi: 10.1084/jem.20140280.
doi: 10.1084/jem.20140280 URL pmid: 26304966 |
[44] |
Okada S, Markle JG, Deenick EK, et al. IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations. Science, 2015,349(6248):606-613. doi: 10.1126/science.aaa4282.
doi: 10.1126/science.aaa4282 URL pmid: 26160376 |
[45] |
Eletto D, Burns SO, Angulo I, et al. Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infection. Nat Commun, 2016,7:13992. doi: 10.1038/ncomms13992.
doi: 10.1038/ncomms13992 URL pmid: 28008925 |
[46] |
Oleaga-Quintas C, Deswarte C, Moncada-Vélez M, et al. A purely quantitative form of partial recessive IFN-γR2 deficiency caused by mutations of the initiation or second codon. Hum Mol Genet, 2018,27(22):3919-3935. doi: 10.1093/hmg/ddy275.
doi: 10.1093/hmg/ddy275 URL pmid: 31222290 |
[47] |
Bhat GJ, Diwan VK, Chintu C, et al. HIV, BCG and TB in children: a case control study in Lusaka, Zambia. J Trop Pediatr, 1993,39(4):219-223. doi: 10.1093/tropej/39.4.219.
doi: 10.1093/tropej/39.4.219 URL pmid: 8411315 |
[48] |
Elenga N, Kouakoussui KA, Bonard D, et al. Diagnosed tuberculosis during the follow-up of a cohort of human immunodeficiency virus-infected children in Abidjan, Côte d'Ivoire: ANRS 1278 study. Pediatr Infect Dis J, 2005,24(12):1077-1082. doi: 10.1097/01.inf.0000190008.91534.b7.
doi: 10.1097/01.inf.0000190008.91534.b7 URL pmid: 16371869 |
[49] |
Hesseling AC, Marais BJ, Gie RP, et al. The risk of disseminated Bacille Calmette-Guérin (BCG) disease in HIV-infected children. Vaccine, 2007,25(1):14-18. doi: 10.1016/j.vaccine.2006.07.020.
doi: 10.1016/j.vaccine.2006.07.020 URL pmid: 16959383 |
[50] |
Armbruster C, Junker W, Vetter N, et al. Disseminated bacille Calmette-Guérin infection in an AIDS patient 30 years after BCG vaccination. J Infect Dis, 1990,162(5):1216. doi: 10.1093/infdis/162.5.1216.
doi: 10.1093/infdis/162.5.1216 URL pmid: 2230251 |
[51] |
Marsh BJ, von Reyn CF, Edwards J, et al. The risks and bene-fits of childhood bacille Calmette-Guérin immunization among adults with AIDS. International MAC study groups. AIDS, 1997,11(5):669-672. doi: 10.1097/00002030-199705000-00015.
doi: 10.1097/00002030-199705000-00015 URL pmid: 9108949 |
[52] | World Health Organization. Releve epidemiologique hebdo-madaire. Wkly Epidemiol Rec, 2007,21(82):181-196. |
[53] |
Anderson EJ, Webb EL, Mawa PA, et al. The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda. Vaccine, 2012,30(12):2083-2089. doi: 10.1016/j.vaccine.2012.01.053.
doi: 10.1016/j.vaccine.2012.01.053 URL pmid: 22300718 |
[54] |
Nissen TN, Birk NM, Kjærgaard J, et al. Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial. Vaccine, 2016,34(22):2477-2482. doi: 10.1016/j.vaccine.2016.03.100.
doi: 10.1016/j.vaccine.2016.03.100 URL pmid: 27060379 |
[55] |
Mostaan S, Yazdanpanah B, Moukhah R, et al. Adverse effects of BCG vaccine 1173 P2 in Iran: A meta-analysis. Adv Biomed Res, 2016,5:99. doi: 10.4103/2277-9175.183659.
doi: 10.4103/2277-9175.183659 URL pmid: 27376038 |
[56] |
Heiman S, Weil M, Shulman LM, et al. Co-appearance of OPV and BCG vaccine-derived complications in two infants with severe combined immunodeficiency. Immunol Res, 2018,66(3):437-443. doi: 10.1007/s12026-018-9007-6.
doi: 10.1007/s12026-018-9007-6 URL pmid: 29804197 |
[57] |
Roxo-Junior P, Silva J, Andrea M, et al. A family history of serious complications due to BCG vaccination is a tool for the early diagnosis of severe primary immunodeficiency. Ital J Pediatr, 2013,39:54. doi: 10.1186/1824-7288-39-54.
doi: 10.1186/1824-7288-39-54 URL pmid: 24016734 |
[1] | LIANG Rui-yun, FANG Wei-jun, REN Hui-li, LI Hui-ru, ZHANG Hui. Study on CT manifestations of non-tuberculous mycobacterium pulmonary disease patients with and without diabetes mellitus [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 962-967. |
[2] | Chinese Antituberculosis Association, Schools and Children Branch of the Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis . Expert consensus of clinical application of the recombinant Mycobacterium tuberculosis fusion protein (EC) [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 761-768. |
[3] | ZHAO Ai-hua, KANG Wan-li, WANG Guo-zhi, GAO Zheng-lun, DU Wei-xin, LU Jin-biao, SHEN Xiao-bing, SU Cheng, XU Miao, ZHENG Su-hua. Screening for latent tuberculosis infection and identification of BCG vaccination by recombinant Mycobacterium tuberculosis 11 kDa [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 821-825. |
[4] | SONG Ke-yu, ZHANG Qin, WANG Wen-jing, SHI Rui, WU Xu-ping. Analysis of drug-resistance of 1719 mycobacterium strains in Nanjing from 2017 to 2019 [J]. Chinese Journal of Antituberculosis, 2020, 42(11): 1214-1220. |
[5] | CHEN Ning, SUN Lin, SHEN A-dong, HE Qiu-shui. Research progress on the non-specific protective effect of BCG [J]. Chinese Journal of Antituberculosis, 2020, 42(10): 1128-1133. |
[6] | Duo LI,Kun FANG,Jue WANG,Zhen ZHOU,Ping-xin LYU. Analysis of CT image classification and clinical characteristics of nontuberculous mycobacterial pulmonary disease [J]. Chinese Journal of Antituberculosis, 2019, 41(2): 202-209. |
[7] | Zhong-nan CHEN,Song-lin YI,Pei-lei HU,Jing-wei GUO,Yan-yan YU,Bin-bin LIU,Huan YI,Kun-yun YANG,Yun-hong TAN. Prevalence of nontuberculosis mycobacterium infection in Hunan Province between 2012 and 2017 [J]. Chinese Journal of Antituberculosis, 2019, 41(2): 217-221. |
[8] | Fang HUANG,Bo WANG,Guo-lian ZHAO,Hai-dong WANG,Li-yun DANG. Diagnosis value of T lymphocyte detection for non-tuberculous mycobacteria diseases [J]. Chinese Journal of Antituberculosis, 2019, 41(12): 1263-1268. |
[9] | Jia YANG,Sheng-xiu LYU,Chun-hua LI,Wei-qiang SHU,Hui-qiu WANG,Guang-xiao TANG,Xue-yan LIU. Comparative analysis of CT findings between Mycobacteria intracellulare lung disease and pulmonary tuberculosis both with cavitation [J]. Chinese Journal of Antituberculosis, 2019, 41(1): 57-63. |
[10] | Wen-wen SUN,Hai LOU,Qin SUN. Short-time efficacy of regimen containing rifabutin in patients with slowly growing mycobacterium lung disease [J]. Chinese Journal of Antituberculosis, 2018, 40(9): 948-953. |
[11] | Fang LI,Wei HE,Xin-hua ZHOU,Chun-sheng ZHAO,Yan LYU,Cheng-hai LI,Dong-po. WANG. The similarities and differences of HRCT imaging features between nontuberculous mycobacterial lung diseases and active pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2018, 40(5): 499-505. |
[12] | Hong-yun YIN,Wen-ling TAN,Jun MA,Yan-ping GE,Xiang SHI,He-ping XIAO,Yong-hong FENG. Analysis of factors influencing T-SPOT.TB results in patients with tuberculosis [J]. Chinese Journal of Antituberculosis, 2018, 40(4): 358-364. |
[13] | LIN Xue,JIA Hui-jun,ZHANG Hui,REN Hui-li,LIU Wen. The value of high resolution CT in the diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases [J]. Chinese Journal of Antituberculosis, 2018, 40(12): 1361-1365. |
[14] | Ai-hua ZHAO,Guo-zhi WANG,Li-li FU,Miao. XU. Comparison of BCG vaccine quality standards of domestic and foreign [J]. Chinese Journal of Antituberculosis, 2018, 40(10): 1125-1128. |
[15] | JIANG Wan-hang, WEI An-na, PANG Hui-min, TAN Shou-yong. Clinical significance of using the simultaneous amplification and testing method (SAT) in the early diagnosis of suspected pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2017, 39(12): 1309-1312. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||